Cardio Vascular Summit

CV SUMMIT IS FOR A BUSY CLINICIAN WITH INTEREST IN CARDIOVASCULAR DISEASE.

5th Annual Diabetes Forum
(Accredited by the College of Family
Physicians of Canada)

Friday, April 23, 2010 The Westin Prince Hotel, Toronto
Program Chair: Lawrence Leiter, MD | Register Now

07:30	Registration and Delegate Breakfast
08:20	Introduction Treatment Recommendations on Diabetes Management	Lawrence Leiter, MD
08:30	Timing and Tailoring: Tackling the challenges of type 2 diabetes in your daily practice: The need for early and aggressive management	Alice Cheng, MD
08:50	New Canadian Dyslipidemia Guidelines: Take home messages	Lawrence Leiter, MD
09:10	The Role of ARB's in Diabetes and Kidney Disease	Murray Berall, MD
09:30	Multiple Risk Factor Management in Patients with Diabetes	David Fitchett, MD
09:50	Panel Discussion and Q & A with Audience Response System	All Faculty
10:20	Nutrition Break
10:40	Challenges in Achieving Metabolic Targets Improving Diabetes Outcomes: How to organize your office	Maureen Clement, MD
11:00	Clinical Management of T2DM: Avoiding the complications of hypoglycemia	Lawrence Leiter, MD
11:20	The Art of Customizing Treatment for Your Patients with Type-2 diabetes	Sol Stern, MD
11:40	Beyond Basal - When is once daily insulin insufficient?	Ronald Goldenberg, MD
12:00	Panel Discussion and Q & A with Audience Response System	All Faculty
12:30	Lunch
13:20	Managing Diabetes in Your Office Case-Based Discussion Case Presentations Panel Discussion and Q & A with Audience Response System	Sol Stern, MD Ronald Goldenberg, MD Lawrence Leiter, MD Anatoly Langer, MD
14:50	Close

(Agenda subject to change)

8th Annual CardioVascular Summit
(Accredited by the College of Family
Physicians of Canada)

Saturday, April 24, 2010 The Westin Prince Hotel, Toronto
Program Chair: Anatoly Langer, MD | Register Now

07:30	Registration and Breakfast
08:20	Welcome	Anatoly Langer, MD
08:30	Management of Cardiovascular Risk in Your Office Protect What Counts	Anil Gupta, MD
08:50	Does Inhibition of Renin Activity Improve Cardiovascular Performance?	Andrew Steele, MD
09:10	Treatment Inertia: An educational program	Murray Berall, MD
09:30	Closing the Care Gap in Cardiovascular Risk Reduction	Anatoly Langer, MD
09:50	Panel Discussion and Q & A with Audience Response System	All Faculty
10:20	Break Innovation in Risk Stratification and Management of Risk Factors
10:40	GRIP: Getting guidelines rolled into practice	Peter Lin, MD
11:20	Practical Tips for Optimizing Success for Smoking Cessation	Lew Pliamm, MD
11:40	Atrial Fibrillation Management Update: New and important developments for practice	Paul Dorian, MD
12:10	Panel Discussion and Q & A with Audience Response System	All Faculty
12:40	LUNCH
13:20	New Targets in Outpatient Management of Atrial Fibrillation · BP lowering: From stroke risk to optimal therapy · Heart age and overall risk · Guidelines based management	Anatoly Langer, MD
14:10	Management of AF in Your Office · Contemporary management of AF in your office · CHADS and recommendations	Anatoly Langer, MD
15:00	Close

(Agenda subject to change)

Learning Objectives:
After completion of this program, participants will be able to:

1.	Understand and interpret results from recently published and presented clinical trials in cardiovascular and metabolic areas.
2.	Implement strategies for managing high-risk patients according to guidelines.
3.	Clearly differentiate between therapies for the treatment of high-risk patients with and without a prior diagnosis of cardiovascular disease.
4.	Differentiate the mechanism of action in the management of all agents available in the cardio-endocrine therapeutic continuum.
5.	Demonstrate improved ability to summarize the results of pre-clinical and clinical studies on therapies for acute coronary syndromes and stable CAD, as well as metabolic syndrome and diabetes.

This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited for up to 5 Mainpro-M1 credits. This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the University of Toronto (5 credits).

Learning Objectives:
After completion of this program, participants will be able to:

1.	Understand and interpret results from recently published and presented clinical trials.
2.	Implement strategies for managing patients with complex cardiovascular disease and risk factors.
3.	Determine the clinical significance of risk stratification and the applicability of the intervention according to the patient's risk.
4.	Clearly differentiate between therapies, medical and pharmaceutical based, for the treatment of patients with and without prior diagnosis of cardiovascular disease.
5.	Have increased ability to differentiate the mechanism of action in the management of disorders such as hypertension, dyslipidemia, diabetes, heart failure and arrhythmia through review of available agents.
6.	Have increased ability to summarize the results of pre-clinical and clinical studies in therapeutic areas such as hypertension, dyslipidemia, diabetes, heart failure and arrhythmia.

This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited for up to 5.5 Mainpro-M1 credits. This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the University of Toronto (5.5 credits).

Faculty and Planning Committee Disclosure of Potential Conflict of Interest
Speakers and planning committee members will be requested to disclose to the audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of this program.